Delayed
London S.E.
12:30:00 03/03/2022 pm IST
|
5-day change
|
1st Jan Change
|
0.0522
USD
|
-.--%
|
|
+0.38%
|
+0.38%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,032
|
5,456
|
10,117
|
16,298
|
16,292
|
-
|
-
|
Enterprise Value (EV)
1 |
7,088
|
7,575
|
12,175
|
18,648
|
16,292
|
16,292
|
16,292
|
P/E ratio
|
6.55
x
|
23.8
x
|
5.82
x
|
-
|
-
|
-
|
-
|
Yield
|
7.72%
|
9.54%
|
15.2%
|
8.24%
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.3
x
|
1.59
x
|
1.8
x
|
2.15
x
|
3.01
x
|
2.76
x
|
2.58
x
|
EV / Revenue
|
1.3
x
|
1.59
x
|
1.8
x
|
2.15
x
|
3.01
x
|
2.76
x
|
2.58
x
|
EV / EBITDA
|
4.28
x
|
4.79
x
|
3.94
x
|
4.75
x
|
9.82
x
|
8.17
x
|
7.53
x
|
EV / FCF
|
11.1
x
|
9.41
x
|
9.65
x
|
6.05
x
|
22.2
x
|
25.4
x
|
20.1
x
|
FCF Yield
|
8.97%
|
10.6%
|
10.4%
|
16.5%
|
4.5%
|
3.93%
|
4.97%
|
Price to Book
|
2.57
x
|
3.82
x
|
4.59
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
1,29,500
|
1,29,479
|
1,29,500
|
1,29,500
|
1,29,500
|
-
|
-
|
Reference price
2 |
38.86
|
42.14
|
78.12
|
125.9
|
125.8
|
125.8
|
125.8
|
Announcement Date
|
21/02/20
|
19/02/21
|
10/02/22
|
03/03/23
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,863
|
3,433
|
5,635
|
7,571
|
-
|
5,416
|
5,897
|
6,306
|
EBITDA
1 |
1,177
|
1,140
|
2,571
|
3,428
|
-
|
1,659
|
1,995
|
2,163
|
EBIT
1 |
804.2
|
779.7
|
2,204
|
3,149
|
-
|
1,254
|
1,526
|
1,638
|
Operating Margin
|
20.82%
|
22.71%
|
39.11%
|
41.59%
|
-
|
23.14%
|
25.87%
|
25.98%
|
Earnings before Tax (EBT)
|
952.6
|
360.7
|
2,145
|
-
|
-
|
-
|
-
|
-
|
Net income
|
768.4
|
229
|
1,738
|
2,455
|
934.8
|
-
|
-
|
-
|
Net margin
|
19.89%
|
6.67%
|
30.84%
|
32.42%
|
-
|
-
|
-
|
-
|
EPS
|
5.932
|
1.772
|
13.43
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
451.5
|
580
|
1,048
|
2,692
|
-
|
733.4
|
640.2
|
809.6
|
FCF margin
|
11.69%
|
16.89%
|
18.59%
|
35.56%
|
-
|
13.54%
|
10.86%
|
12.84%
|
FCF Conversion (EBITDA)
|
38.36%
|
50.89%
|
40.76%
|
78.52%
|
-
|
44.21%
|
32.09%
|
37.42%
|
FCF Conversion (Net income)
|
58.76%
|
253.32%
|
60.29%
|
109.66%
|
-
|
-
|
-
|
-
|
Dividend per Share
|
2.999
|
4.019
|
11.85
|
10.37
|
-
|
-
|
-
|
-
|
Announcement Date
|
21/02/20
|
19/02/21
|
10/02/22
|
03/03/23
|
26/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
2,056
|
2,119
|
2,058
|
2,349
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.747
x
|
1.859
x
|
0.8005
x
|
0.6853
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
451
|
580
|
1,048
|
2,692
|
-
|
733
|
640
|
810
|
ROE (net income / shareholders' equity)
|
33.5%
|
14.7%
|
95.4%
|
-
|
-
|
45.5%
|
43.1%
|
37.8%
|
ROA (Net income/ Total Assets)
|
-
|
5.42%
|
35.8%
|
-
|
-
|
14.3%
|
15.7%
|
15.4%
|
Assets
|
-
|
4,226
|
4,861
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
15.10
|
11.00
|
17.00
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
8.630
|
4.480
|
13.10
|
14.20
|
-
|
-
|
-
|
-
|
Capex
1 |
666
|
553
|
642
|
847
|
-
|
846
|
870
|
870
|
Capex / Sales
|
17.25%
|
16.11%
|
11.39%
|
11.19%
|
-
|
15.63%
|
14.75%
|
13.79%
|
Announcement Date
|
21/02/20
|
19/02/21
|
10/02/22
|
03/03/23
|
26/04/24
|
-
|
-
|
-
|
Last Close Price
125.8
USD Average target price
64.21
USD Spread / Average Target -48.96% Consensus |
1st Jan change
|
Capi.
|
---|
| +9.43% | 36.55B | | +26.24% | 7.88B | | +7.90% | 6.88B | | -12.58% | 6.88B | | -11.17% | 5.64B | | -10.25% | 5.37B | | -2.57% | 5.15B | | +27.31% | 5.01B | | +5.71% | 3.95B |
Other Agricultural Chemicals
|